Sign In

Ittai Harel

Managing General Partner at Pitango Venture Capital

Ittai Harel is a prominent figure in the health technology sector, currently serving as a Board Member at 8400 The Health Network. He is also the Managing General Partner at Pitango Venture Capital, a role he has held since July 2006, where he focuses on investments in digital health, medical devices, diagnostics, and therapeutic development companies. Harel has extensive experience in advising and assisting entrepreneurs and management teams in the growth of their companies.13

Professional Background

  • 8400 The Health Network: Board Member, contributing to initiatives that support HealthTech startups.

  • Pitango Venture Capital: Managing General Partner, leading investments and strategic guidance in the health sector.

  • Board Positions: Harel holds various director roles on the boards of multiple companies, including:

    • QuantHealth (2023 - Present)
    • Protai (2022 - Present)
    • Connie Health (2021 - Present)
    • ImmuneID (2021 - Present)
    • Homethrive, Inc (2020 - Present)
    • Medisafe® (2015 - Present)
    • DouxMatok (2017 - Present) among others.123

Education

Harel holds a Bachelor of Science in Chemical Engineering and Biotechnology from Ben-Gurion University of the Negev (1989-1993) and a Master of Science in Management and Marketing from the MIT Sloan School of Management (1993-1995)【2】.

His extensive background in both entrepreneurship and investment positions him as a key player in advancing health technology innovations.

Highlights

Aug 22 · linkedin

Thrilled to congratulate the phenomenal Vertos Medical team on their acquisition by Stryker

This acquisition marks a major milestone in the transformation of care for millions of individuals suffering from debilitating back pain caused by Lumbar Spinal Stenosis. And will further accelerate access to Mild procedure- a proven effective, safe, minimally invasive solution for those suffering from LSS

Pitango is proud to support Vertos Medical ever since leading its financing in 2013. At that time, a young medical device company with challenges on every front. Fast forward several years, and the company's product Mild has seen vast adoption in the US by clinicians, strong reimbursement, large and fast growing commercial footprint, all led by a fantastic 150+ person team

It has been an honor to serve on the company's board with wonderful co-investors such as Daniel Pelak, Hugo Harrod from MVM Partners, Michael Boggs from LRP and Zack Scott from Norwest Venture Partners. And special mention to John Ryan as well.

Proud of you all. Congrats - Eric Wichems, Rebecca Colbert, Steve Paul karen Davis, Dave Lalor, Hugh Neuharth Mehrzad Mehrzad Khakpour, PhD

From The Pitango team Ittai Harel Jonathan Glazer, MD, MBA, Hila Karah, Chemi Peres, Rami Kalish

Aug 13 · linkedin

Thrilled to announce that Protai has been chosen as one of TheMarker's 20 Most Promising Companies! 🎉 Protai's innovative end-to-end AI-based platform is revolutionizing the way we understand diseases at the protein level, enhancing our ability to observe cellular function and transforming the drug discovery process. 💡🔝

Congrats to Eran Seger, Kirill Pevzner and the team! I’m incredibly proud of Protai's achievements and their pioneering spirit in the biotech industry 🚀

Stay tuned to see how Protai continues to shape the future of medicine! 🌟

Read more here: https://lnkd.in/dqPmcAUb

#Innovation #Biotech #AI #Healthcare

Related Questions

What are Ittai Harel's main responsibilities at 8400 The Health Network?
How has Ittai Harel's experience at Pitango Venture Capital influenced his role at 8400 The Health Network?
What are some notable companies Ittai Harel has invested in through Pitango Venture Capital?
How does Ittai Harel's background in chemical engineering and biotechnology impact his work in health technology?
What are the key projects Ittai Harel has led or been involved in at 8400 The Health Network?
Ittai Harel
Ittai Harel, photo 1
Ittai Harel, photo 2
Add to my network

Experience

Managing General Partner at Pitango Venture Capital (July 2006 - Present)
Director Board of Directors at QuantHealth (January 2023 - Present), Protai (January 2022 - Present), Connie Health (April 2021 - Present), ImmuneID (January 2021 - Present), Homethrive, Inc (October at IDEXX Laboratories (May 1994 - April 2000)

Education

M.Sc. in Management and Marketing from MIT Sloan School of Management (1993 - 1995), B.Sc. in Chemical Engineering and Biotechnology from Ben-Gurion University of the Negev (1989 - 1993)

Location

Israel